Seattle, WA, United States of America

Steven R Wiley

This inventor holds 23 USPTO granted patents and 3 published patent applications and 5 EPO patents, primarily in Immunology Research. Top assignees: Immunex Corporation, Adaptive Biotechnologies Corporation, Amgen Inc.. Active years: 1998-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Steven R Wiley. Retrieved from https://idiyas.com/inventor/steven-r-wiley

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 23 

% Patents Active = 26.1

 

Average Co-Inventor Count = 1.6

ph-index = 8

Forward Citations = 318(Granted Patents)


Company Filing History:


Years Active: 1998-2019

Loading Chart...
Loading Chart...
Areas of Expertise:
Monoclonal Antibodies
TWEAK Receptor
Immunological Diseases
Polypeptide Targets
TRAIL Polypeptides
Apoptosis
Cytokines
Claudin Polypeptides
Human Serpin Polypeptides
Immunity Profiling
Multimeric Fragments
Oligomeric Fragments
23 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Steven R. Wiley

Introduction: Steven R. Wiley, a prominent inventor based in Seattle, WA, has made significant contributions to the field of biotechnology, boasting an impressive portfolio of 23 patents. His innovative work primarily focuses on adaptive immunity profiling and monoclonal antibody production, showcasing his dedication to advancing medical science.

Latest Patents: Among his latest patents are two remarkable inventions. The first is titled "Adaptive immunity profiling and methods for generation of monoclonal antibodies," which presents methods for efficiently producing monoclonal antibody candidates using adaptive immunity profiling techniques. This process incorporates the use of massively parallel signature sequencing, an advanced methodology that enhances the precision of antibody development. The second patent, titled "Tweak receptor," offers vital insights into the TWEAK receptor and outlines methods for identifying agonists and antagonists. This invention provides innovative methods for screening compounds to treat diseases linked to angiogenesis, including solid tumors and vascular deficiencies in cardiac or peripheral tissues.

Career Highlights: Steven has notably worked at leading companies in the biotechnology sector, including Immunex Corporation and Imdaptive, Inc. His tenure at these organizations has allowed him to refine his skills and contribute to cutting-edge research and development in immunology.

Collaborations: Throughout his career, Steven has had the privilege of collaborating with distinguished professionals in his field, including Raymond G. Goodwin and Kristine M. Kim. These collaborations have facilitated the exchange of ideas and have further propelled his research endeavors.

Conclusion: Steven R. Wiley's inventive spirit and dedication to scientific advancement are evident through his numerous patents and collaborative efforts. His work has profoundly impacted biotechnology and medicine, paving the way for new treatments and therapies that address critical health challenges. Steven continues to inspire the next generation of inventors in the ever-evolving landscape of biomedical research.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…